B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)

D L Petersen; T Krejsgaard; J Berthelsen; S Fredholm; A Willerslev-Olsen; N A Sibbesen; C M Bonefeld; M H Andersen; Chiara Francavilla; J V Olsen; Teng Hu; M Zhang; M A Wasik; C Geisler; A Woetmann; N Odum

doi:10.1038/leu.2014.192

B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)

D L Petersen, T Krejsgaard, J Berthelsen, S Fredholm, A Willerslev-Olsen, N A Sibbesen, C M Bonefeld, M H Andersen, Chiara Francavilla, J V Olsen, Teng Hu, M Zhang, M A Wasik, C Geisler, A Woetmann, N Odum

Center for Cancer Immune Therapy (CCIT), Department of Oncology, Copenhagen University Hospital , Herlev, Denmark.

36 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Leukemia
Vol/bind	28
Udgave nummer	10
Sider (fra-til)	2109-12
Antal sider	4
ISSN	0887-6924
DOI	https://doi.org/10.1038/leu.2014.192
Status	Udgivet - okt. 2014

Adgang til dokumentet

10.1038/leu.2014.192

Citationsformater

Petersen, D. L., Krejsgaard, T., Berthelsen, J., Fredholm, S., Willerslev-Olsen, A., Sibbesen, N. A., Bonefeld, C. M., Andersen, M. H., Francavilla, C., Olsen, J. V., Hu, T., Zhang, M., Wasik, M. A., Geisler, C., Woetmann, A., & Odum, N. (2014). B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL). Leukemia, 28(10), 2109-12. https://doi.org/10.1038/leu.2014.192

Petersen, DL, Krejsgaard, T, Berthelsen, J, Fredholm, S, Willerslev-Olsen, A, Sibbesen, NA, Bonefeld, CM, Andersen, MH, Francavilla, C, Olsen, JV, Hu, T, Zhang, M, Wasik, MA, Geisler, C, Woetmann, A & Odum, N 2014, 'B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)', Leukemia, bind 28, nr. 10, s. 2109-12. https://doi.org/10.1038/leu.2014.192

@article{2452004bd9c24c00808623a1a345ed92,

title = "B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)",

keywords = "Animals, Cell Line, Tumor, Cell Proliferation, Gene Expression Regulation, Neoplastic, Humans, Lymphoma, T-Cell, Cutaneous, Mice, Neoplasm Transplantation, Neoplasms, Phosphorylation, Pyrimidines, Thiazoles, src-Family Kinases",

author = "Petersen, {D L} and T Krejsgaard and J Berthelsen and S Fredholm and A Willerslev-Olsen and Sibbesen, {N A} and Bonefeld, {C M} and Andersen, {M H} and Chiara Francavilla and Olsen, {J V} and Teng Hu and M Zhang and Wasik, {M A} and C Geisler and A Woetmann and N Odum",

year = "2014",

month = oct,

doi = "10.1038/leu.2014.192",

language = "English",

volume = "28",

pages = "2109--12",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)

AU - Petersen, D L

AU - Krejsgaard, T

AU - Berthelsen, J

AU - Fredholm, S

AU - Willerslev-Olsen, A

AU - Sibbesen, N A

AU - Bonefeld, C M

AU - Andersen, M H

AU - Francavilla, Chiara

AU - Olsen, J V

AU - Hu, Teng

AU - Zhang, M

AU - Wasik, M A

AU - Geisler, C

AU - Woetmann, A

AU - Odum, N

PY - 2014/10

Y1 - 2014/10

KW - Animals

KW - Cell Line, Tumor

KW - Cell Proliferation

KW - Gene Expression Regulation, Neoplastic

KW - Humans

KW - Lymphoma, T-Cell, Cutaneous

KW - Mice

KW - Neoplasm Transplantation

KW - Neoplasms

KW - Phosphorylation

KW - Pyrimidines

KW - Thiazoles

KW - src-Family Kinases

U2 - 10.1038/leu.2014.192

DO - 10.1038/leu.2014.192

M3 - Journal article

C2 - 24919804

SN - 0887-6924

VL - 28

SP - 2109

EP - 2112

JO - Leukemia

JF - Leukemia

IS - 10

ER -